MMIRF (MedMira) OCF Margin %: -1,083.33% (As of Jan. 2026)


What is MedMira OCF Margin %?

MedMira MMIRF +302.48% OCF Margin % is -1,083.33% as of Jan. 2026. The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, MedMira ranks worse than 80.81% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. MedMira's Cash Flow from Operations for the three months ended in Jan. 2026 was $-0.20 Mil. MedMira's Revenue for the three months ended in Jan. 2026 was $0.02 Mil. Therefore, MedMira's OCF Margin % for the quarter that ended in Jan. 2026 was -1,083.33%.

As of today, MedMira's current OCF Yield % is -4.30%.

The historical rank and industry rank for MedMira's OCF Margin % or its related term are showing as below:

MMIRF' s OCF Margin % Range Over the Past 10 Years
Min: -1304.98   Med: -189.63   Max: -23.55
Current: -1039.71

During the past 13 years, the highest OCF Margin % of MedMira was -23.55%. The lowest was -1304.98%. And the median was -189.63%.

MMIRF's OCF Margin % is ranked worse than
80.81% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs MMIRF: -1039.71

MedMira OCF Margin % Related Terms

MedMira OCF Margin % Historical Data

* Premium members only.

The historical data trend for MedMira's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira OCF Margin % Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.55 -197.83 -292.68 -711.96 -1,305.11

MedMira Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,027.08 -1,569.05 -1,021.62 -466.67 -1,083.33

MMIRF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, MedMira's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's OCF Margin % distribution charts can be found below:

* The bar in red indicates where MedMira's OCF Margin % falls into.


MedMira OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

MedMira's OCF Margin for the fiscal year that ended in Jul. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-2.297/0.176
=-1,305.11 %

MedMira's OCF Margin for the quarter that ended in Jan. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-0.195/0.018
=-1,083.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1,083.33% mean?
MedMira (MMIRF) has a OCF Margin % of -1,083.33% as of Jan. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on MedMira and its competitors. According to the industry distribution chart, MedMira ranks #775 out of 959 companies in the Biotechnology industry, placing it in the top 80.8%.
Is MedMira's OCF Margin % too high?
MedMira's current OCF Margin % is -1,083.33%. Based on the distribution chart, MedMira ranks #775 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does MedMira's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MedMira ranks #775 out of 959 companies for OCF Margin %. This places MedMira in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on MedMira and its competitors. MedMira's current OCF Margin % is -1,083.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current OCF Margin % of -1,083.33%. The current OCF Margin % is -1,083.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For MedMira (MMIRF), the current OCF Margin % is -1,083.33% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.